Nestlé keeps it short and sweet with €500m at 5bp over

Nestlé today returned to the euro bond market for the third time since announcing its $11.85bn acquisition of Pfizer’s infant nutrition business in April. Many investors in Europe are now more hungry for spread than safety, so the €500m deal was more muted than some of Nestlé’s, but it still priced extremely tightly.